2026-2034年全球輻射中毒治療市場規模、佔有率、趨勢和成長分析報告

全球輻射中毒治療市場預計將從2025年的17.7億美元成長到2034年的29.9億美元，2026年至2034年的複合年成長率（CAGR）為5.98%。該市場穩步擴張的原因在於接受放射治療的癌症患者人數不斷增加，以及對支持性護理以應對治療相關副作用的需求日益成長。目前，針對影響皮膚、胃腸道、口腔和其他器官的放射毒性的有效治療方法的需求持續存在。醫療專業人員正著重於提供全面的支持性護理，以提高患者的舒適度、治療依從性和整體臨床療效。

癌症發生率上升、放射腫瘤服務不斷擴展以及支持治療的進步是推動產業發展的關鍵因素。製藥公司正在研發創新藥物和再生醫學方法，旨在減少組織損傷並促進復原。醫護人員對早期毒性管理的認知不斷提高，也有助於提高癌症中心的治療使用率。

鑑於再生醫學、生物製藥、幹細胞療法和標靶保護劑等領域的研究持續取得進展，前景依然樂觀。個人化支持治療方案和人工智慧驅動的毒性預測工具有望顯著改善患者管理。增加對綜合癌症治療基礎設施的投資以及腫瘤治療領域的持續創新，將為該行業的長期成長創造持續機會。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節對市場進行了清晰的說明，包括關鍵定義、分類以及當前行業格局的概述。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分根據產品類型、應用、最終用戶和地區將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業進行了詳細評估，包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭趨勢和主要參與者所採取的策略。

市場預測：本部分提供基於數據的市場規模和成長模式預測，預測期為指定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析，以識別預期的未來趨勢。

區域分析：這包括對主要地理區域的市場表現進行全面檢驗，確定高成長領域和區域趨勢，以更深入地了解每個區域特有的市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的報告客製化服務，以滿足您的特定需求。這包括額外的細分、國家/地區分析、競爭對手分析、客製化資料點或針對特定細分市場的洞察，從而更有效地支援您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球輻射中毒治療市場：依藥物類別分類

• 市場分析、洞察與預測
• 細胞保護劑
• 唾液分泌促效劑/膽鹼能促效劑
• 局部皮質類固醇
• 局部麻醉劑
• 用於胃腸道的抗發炎藥物和黏膜保護劑
• 止痛藥
• 其他

第5章：全球輻射中毒治療市場：依疾病適應症分類

• 市場分析、洞察與預測
• 口腔黏膜炎
• 放射性皮膚炎
• 口乾症/唾液腺功能障礙
• 放射性直腸炎
• 放射性食道炎
• 放射性腸炎
• 其他

第6章 全球輻射中毒治療市場：依年齡層別分類

• 市場分析、洞察與預測
• 兒童
• 成人

第7章 全球輻射中毒治療市場：按類型分類

• 市場分析、洞察與預測
• 品牌
• 非專利的

第8章：全球輻射中毒治療市場：依給藥途徑分類

• 市場分析、洞察與預測
• 口服
• 外用
• 腸外
• 直腸
• 其他

第9章 全球輻射中毒治療市場：依通路分類

• 市場分析、洞察與預測
• 醫院藥房
• 藥局和零售藥房
• 網路藥房

第10章 全球輻射中毒治療市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第11章 競爭格局

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第12章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Galera Therapeutics Inc
  • KeraNetics Inc
  • Monopar Therapeutics Inc
  • Partner Therapeutics Inc
  • Recordati SpA
  • Soligenix Inc
  • Soleva Pharma LLC
  • Solventum
  • Stratpharma AG

The global radiation toxicity treatment market size is expected to reach USD 2.99 Billion in 2034 from USD 1.77 Billion in 2025, growing at a CAGR of 5.98 during 2026-2034.This market is expanding steadily as increasing numbers of cancer patients undergo radiation therapy and require supportive treatments to manage therapy-related side effects. Radiation-induced toxicity affecting the skin, gastrointestinal tract, oral cavity, and other organs is creating consistent demand for effective therapeutic solutions. Healthcare providers are emphasizing comprehensive supportive care to improve patient comfort, treatment adherence, and overall clinical outcomes.

Growing cancer prevalence, expanding radiation oncology services, and advancements in supportive care therapies are key factors supporting industry development. Pharmaceutical companies are developing innovative medications and regenerative treatment approaches designed to reduce tissue damage and accelerate recovery. Increasing awareness among healthcare professionals regarding early toxicity management is also contributing to improved treatment utilization across oncology centers.

Future prospects remain favorable as research into regenerative medicine, biologics, stem cell therapies, and targeted protective agents continues advancing. Personalized supportive care protocols and artificial intelligence-assisted toxicity prediction tools are expected to improve patient management significantly. Rising investments in comprehensive cancer care infrastructure and continued innovation in oncology therapeutics will create sustained opportunities for long-term industry growth.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Drug Class

• Cytoprotective Agents
• Salivary Stimulants/Cholinergic Agonists
• Topical Corticosteroids
• Topical Local Anesthetics
• Gastrointestinal Anti-inflammatory & Mucosal Protectants
• Analgesics
• Others

By Disease Indication

• Oral Mucositis
• Radiation Dermatitis
• Xerostomia/Salivary Gland Dysfunction
• Radiation Proctitis
• Radiation Esophagitis
• Radiation Enteritis
• Others

By Age Group

• Pediatric
• Adults

By Type

• Branded
• Generic

By Route of Administration

• Oral
• Topical
• Parenteral
• Rectal
• Others

By Distribution Channel

• Hospital Pharmacies
• Drug Stores & Retail Pharmacies
• Online Pharmacies

COMPANIES PROFILED

• Galera Therapeutics Inc., KeraNetics Inc., Monopar Therapeutics Inc., Partner Therapeutics Inc., Recordati S.p.A., Soligenix Inc., Soleva Pharma LLC, Solventum, Stratpharma AG

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL RADIATION TOXICITY TREATMENT MARKET: BY DRUG CLASS 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Drug Class
• 4.2. Cytoprotective Agents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Salivary Stimulants/Cholinergic Agonists Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Topical Corticosteroids Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Topical Local Anesthetics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Gastrointestinal Anti-inflammatory & Mucosal Protectants Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Analgesics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL RADIATION TOXICITY TREATMENT MARKET: BY DISEASE INDICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Disease Indication
• 5.2. Oral Mucositis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Radiation Dermatitis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Xerostomia/Salivary Gland Dysfunction Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Radiation Proctitis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Radiation Esophagitis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Radiation Enteritis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL RADIATION TOXICITY TREATMENT MARKET: BY AGE GROUP 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Age Group
• 6.2. Pediatric Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Adults Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL RADIATION TOXICITY TREATMENT MARKET: BY TYPE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Type
• 7.2. Branded Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Generic Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL RADIATION TOXICITY TREATMENT MARKET: BY ROUTE OF ADMINISTRATION 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast Route Of Administration
• 8.2. Oral Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Topical Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Parenteral Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.5. Rectal Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL RADIATION TOXICITY TREATMENT MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 9.1. Market Analysis, Insights and Forecast Distribution Channel
• 9.2. Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.3. Drug Stores & Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.4. Online Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 10. GLOBAL RADIATION TOXICITY TREATMENT MARKET: BY REGION 2022-2034 (USD MN)

• 10.1. Regional Outlook
• 10.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.2.1 By Drug Class
  • 10.2.2 By Disease Indication
  • 10.2.3 By Age Group
  • 10.2.4 By Type
  • 10.2.5 By Route Of Administration
  • 10.2.6 By Distribution Channel
  • 10.2.7 United States
  • 10.2.8 Canada
  • 10.2.9 Mexico
• 10.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.3.1 By Drug Class
  • 10.3.2 By Disease Indication
  • 10.3.3 By Age Group
  • 10.3.4 By Type
  • 10.3.5 By Route Of Administration
  • 10.3.6 By Distribution Channel
  • 10.3.7 United Kingdom
  • 10.3.8 France
  • 10.3.9 Germany
  • 10.3.10 Italy
  • 10.3.11 Russia
  • 10.3.12 Rest Of Europe
• 10.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.4.1 By Drug Class
  • 10.4.2 By Disease Indication
  • 10.4.3 By Age Group
  • 10.4.4 By Type
  • 10.4.5 By Route Of Administration
  • 10.4.6 By Distribution Channel
  • 10.4.7 India
  • 10.4.8 Japan
  • 10.4.9 South Korea
  • 10.4.10 Australia
  • 10.4.11 South East Asia
  • 10.4.12 Rest Of Asia Pacific
• 10.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.5.1 By Drug Class
  • 10.5.2 By Disease Indication
  • 10.5.3 By Age Group
  • 10.5.4 By Type
  • 10.5.5 By Route Of Administration
  • 10.5.6 By Distribution Channel
  • 10.5.7 Brazil
  • 10.5.8 Argentina
  • 10.5.9 Peru
  • 10.5.10 Chile
  • 10.5.11 Rest of Latin America
• 10.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.6.1 By Drug Class
  • 10.6.2 By Disease Indication
  • 10.6.3 By Age Group
  • 10.6.4 By Type
  • 10.6.5 By Route Of Administration
  • 10.6.6 By Distribution Channel
  • 10.6.7 Saudi Arabia
  • 10.6.8 UAE
  • 10.6.9 Israel
  • 10.6.10 South Africa
  • 10.6.11 Rest of the Middle East And Africa

Chapter 11. COMPETITIVE LANDSCAPE

• 11.1. Recent Developments
• 11.2. Company Categorization
• 11.3. Supply Chain & Channel Partners (based on availability)
• 11.4. Market Share & Positioning Analysis (based on availability)
• 11.5. Vendor Landscape (based on availability)
• 11.6. Strategy Mapping

Chapter 12. COMPANY PROFILES OF GLOBAL RADIATION TOXICITY TREATMENT INDUSTRY

• 12.1. Top Companies Market Share Analysis
• 12.2. Company Profiles
  • 12.2.1 Galera Therapeutics Inc
  • 12.2.2 KeraNetics Inc
  • 12.2.3 Monopar Therapeutics Inc
  • 12.2.4 Partner Therapeutics Inc
  • 12.2.5 Recordati S.p.A
  • 12.2.6 Soligenix Inc
  • 12.2.7 Soleva Pharma LLC
  • 12.2.8 Solventum
  • 12.2.9 Stratpharma AG